sTLR4的研究进展(3)

　　[4]Hyakushima N, Mitsuzawa H, Nishitani C, et al.Interaction of soluble form of recombinant extracellular TLR4 domain with MD-2enables lipopolysaccharide binding and attenuates TLR4-mediated signaling[J].Immunol, 2004, 173 （11） :6949-6954.　　

　　[5]Mitsuzawa H, Nishitani C, Hyakushima N, et al.Recombinant soluble forms of extracellular TLR4 domain and MD-2 inhibit lipopolysaccharide binding on cell surface and dampen lipopolysaccharide-induced pulmonary inflammation in mice[J].Immunology, 2006, 177 （11） :8133-8139.　　

　　[6]Zou Y, Qin F, Chen J, et al.s TLR4/MD-2 complex inhibits colorectal cancer in vitro and in vivo by targeting LPS[J].Oncotarget, 2016, 7 （32） :52032-52044.

　　[7]Zunt SL, Burton LV, Goldblatt LI, et al.Soluble forms of Toll-like receptor 4 are present in human saliva and modulate tumour necrosis factor-alpha secretion by macrophage-like cells[J].Clin Exp Immunol, 2009, 156 （2） :285-293.